Purvalanol B

CAS: 212844-54-7

Ref. 3D-MIA84454

Produktinformation

• Name: Purvalanol B
• Marke: Biosynth
• Beschreibung: Purvalanol B is a selective cyclin-dependent kinase (CDK) inhibitor, which is synthetically derived through chemical synthesis. With high specificity, it inhibits CDK activity by competitively binding to the ATP-binding site of these kinases, thereby blocking substrate phosphorylation and subsequent cell cycle progression. Purvalanol B's mechanism of action allows it to interfere with CDK-dependent processes, making it a valuable tool in elucidating cell cycle dynamics and the molecular underpinnings of cancer proliferation.

Chemische Eigenschaften

• Molekulargewicht: 432.9 g/mol
• Formel: C₂₀H₂₅ClN₆O₃
• Reinheit: Min. 95%